| |
| |
|
| Insider
Information: |
Gilad Oren |
| Relationship: |
President/CEO, Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
333,395 |
|
|
Indirect Shares
|
1,800 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
335,195 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aprea Therapeutics, Inc. |
APRE |
President/CEO, Director |
2024-10-23 |
333,395 |
2024-10-23 |
1,800 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
President |
• • – |
2022-05-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
229,014 |
|
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President, CEO |
• – – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
101,300 |
330,314 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President, CEO |
• • – |
2022-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,045,100 |
6,375,414 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President, CEO |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
322,770 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President, CEO |
• • – |
2024-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,725 |
331,495 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President/CEO |
• • – |
2024-10-10 |
4 |
B |
$2.54 |
$381 |
D/D |
150 |
331,645 |
2.73 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President/CEO |
• • – |
2024-10-14 |
4 |
B |
$2.59 |
$2,590 |
D/D |
1,000 |
332,645 |
2.73 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President/CEO |
• • – |
2024-10-15 |
4 |
B |
$2.90 |
$725 |
D/D |
250 |
332,895 |
2.73 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President/CEO |
• • – |
2024-10-23 |
4 |
B |
$3.92 |
$1,958 |
D/D |
500 |
333,395 |
2.73 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
President, CEO |
• • – |
2024-03-13 |
4 |
B |
$7.29 |
$14,580 |
D/D |
2,000 |
324,770 |
2.81 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
